Management holds a conference call to discuss Tavapadon in Parkinson’s Disease on December 11 at 10 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CERE:
- Cerevel Therapeutics just downgraded at TD Cowen, here’s why
- Cerevel Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
- After AbbVie agrees to buy Cerevel, analysts weigh in on who may be next
- Cerevel Therapeutics downgraded to Neutral from Overweight at Piper Sandler
- Cerevel Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald